Slow Transit Constipation
13
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (13)
YQD Combined With Plant Lactobacillus for Slow Transit Constipation
Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation
STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation
Preoperative Fish Oil PN and Prognosis After Constipation Surgery
Validation of New Type Radiopaque Marker in The Evaluation of Colonic Transit Time
MSOT and MRI for Non-invasive Assessment of Intestinal Transit Time in Children With Chronic Bowel Emptying Disorders
Comparison of the Atmo Motility Gas Capsule System to the Reference Standard
Using 16S rRNA Gene Sequencing Analysis Intestinal Microbiota in Constipation Patients
Effect of Fecal Microbiota Transplantation in Slow Transit Constipation
Efficacy and Safety of Fecal Microbiota Transplantation for Slow Transit Constipation
Effect of a Synbiotic on Symptoms of Patients With STC
Freeze-dried vs Fresh Fecal Microbiota Transplantation in Patients With Slow Transit Constipation
Evaluating the Synergism of Soluble Dietary Fiber With Fecal Microbiota Transplantation in Slow Transit Constipation